Leadless pacemaker used with the EMBLEM S-ICD System: The First Report on Communicating Leadless Anti-Tachycardia Pacemaker and S-ICD: The Next Step in Cardiac Rhythm Management: Fleur Tjong, M.D., will present on Monday, April 4 at 9:45 AM in the Arrhythmias and Clinical EP Moderated Poster Theater, South Hall A.
Structural Heart
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The Lotus Valve System: Feasibility of Direct Aortic Implantation of the Lotus Valve: a Multicenter Experience: Leo Ihlberg, M.D., Ph.D., will present on Saturday, April 2 at 10:00 AM in the Valvular Heart Disease Moderated Poster Theater, South Hall A.
WATCHMAN Device: Post-FDA Approval Experience of LAAC in the United States: David R. Holmes, M.D., will present on Saturday, April 2 at 10:45 AM in the Arrhythmias and Clinical EP Moderated Poster Theater, South Hall A.
The Lotus Valve System: Outcomes With Predilatation Versus No Predilatation in Routine Clinical Practice With the Lotus Valve: Results From the First 500 Patients Enrolled in the RESPOND Study: Nicolas Van Mieghem, M.D., will present on Saturday, April 2 at 4:15 PM in the Valvular Heart Disease Moderated Poster Theater, South Hall.
The Lotus Valve System: Post-Market Evaluation of a Fully Repositionable and Retrievable Aortic Valve in 750 Patients Treated in Routine Clinical Practice: An Update From the RESPOND Study: Nicolas Van Mieghem, M.D., will present on Monday, April 4 at 8:15 AM in Room S405.
All programs are listed in Central Time and will take place at the Chicago McCormick Place Convention Center. For more information, visit Boston Scientific at booth #12026.
The company will also host an investor event and webcast on April 4 from 7:00 – 8:00 AM CDT to provide a presentation and answer questions from investors about the Boston Scientific cardiovascular portfolio. The event will be accessible via live webcast at www.bostonscientific.com/investors. A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.
Caution: The Lotus Valve System is an investigational device limited under U.S. Federal law to investigational use only and not available for sale in the U.S. The leadless pacemaker is a concept device or technology. Not available for use or sale.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
